...heterozygous pigs. Immerge is a joint venture between Novartis AG (NVS; SWX:NOVN, Basel, Switzerland) and BioTransplant Inc....

...for Chapter 11, said the deal is subject to approval of the U.S. Bankruptcy Court. BioTransplant Inc....

...in psoriasis, the indication for which it is in Phase II (see BioCentury, April 28). BioTransplant Inc....

...of antibody-mediated rejection. Data were presented at the American Transplant Congress meeting in Washington, D.C. BioTransplant Inc....

...for Chapter 11, said the deal is subject to approval of the U.S. Bankruptcy Court. BioTransplant Inc....

...therapy Hired: James Embree as SVP of operations, formerly SVP of manufacturing and development at BioTransplant...

...completion of a Phase II psoriasis trial of Vitaxin, MEDI's monoclonal antibody against integrin alpha(v)-beta(3). BioTransplant Inc....

...BioCentury, Oct. 28, 2002). BTRN is reorganizing under Chapter 11 of the U.S. Bankruptcy Code. BioTransplant Inc....

...Johnson Remicade infliximab TNF alpha inhibitor Ph II Schering-Plough MedImmune Siplizumab Anti-CD2 antibody Ph II BioTransplant...

...AG (NVS; SWX:NOVN, Basel, Switzerland) a sublicense to MEDI-507 for use with a xenotransplantation system. BioTransplant Inc....